Noninvasive OptiLift addresses ‘root cause’ of dry eye

Key takeaways:

OptiLift improved lower eyelid laxity and meibomian gland function and reduced dry eye symptoms.

The noninvasive treatment consisted of 10-minute weekly sessions.

Noninvasive 10-minute treatments with OptiLift led to significant improvements in lower lid laxity, dry eye symptoms and meibomian gland function within 4 weeks, according to a study published in Clinical Ophthalmology .

The finding shows the promise of dynamic muscle stimulation technology with OptiLift (Lumenis) to address a “root cause” of dry eye disease, James G. Chelnis , MD , of Manhattan Face and Eye, told Healio.

“We have found that as we get more comfortable with this technology, there really are a lot of powerful uses outside of what it was initially vetted or brought to market for,” Che